MediciBIO Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
MediciBIO Co., Ltd. - overview
Established
2021
Location
Yongin, Gyeonggido, South Korea
Primary Industry
Biotechnology
About
Based in Yongin, South Korea, founded in 2021, MediciBIO Co. , Ltd. operates as a company that develops lipid nanoparticle drug delivery technologies for gene-based medicines. The company creates proprietary lipid carriers that improve the delivery of RNA and DNA therapies, vaccines, and treatments for genetic diseases while aiming to reduce immune reactions and side effects.
Current Investors
Kolon Investment, ES Investor, Daedeok Venture Partners
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.medicibio.co.kr/
Company Stage
Series A
Total Amount Raised
Subscriber access only
MediciBIO Co., Ltd. - financials
| Fiscal Year Ended | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue (USD) | - | 120,000,000 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - |
| EBITDA (USD) | - | - | - | - | - |
| Operating Income (USD) | (102,000,000) | (1,069,000,000) | - | - | - |
| Operating Margin | - | (890.8%) | - | - | - |
| % EBITDA Margin | - | - | - | - | - |
| NET Income (USD) | (102,000,000) | (1,074,000,000) | - | - | - |
| % Net Margin | - | (895.0%) | - | - | - |
MediciBIO Co., Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A | Completed | MediciBIO Co., Ltd. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.